BE641880A - - Google Patents

Info

Publication number
BE641880A
BE641880A BE641880A BE641880A BE641880A BE 641880 A BE641880 A BE 641880A BE 641880 A BE641880 A BE 641880A BE 641880 A BE641880 A BE 641880A BE 641880 A BE641880 A BE 641880A
Authority
BE
Belgium
Application number
BE641880A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE641880A publication Critical patent/BE641880A/xx

Links

BE641880A 1962-12-27 1963-12-27 BE641880A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP5790262 1962-12-27
JP5741963 1963-10-29
JP6427663 1963-10-29
JP6250163 1963-11-22

Publications (1)

Publication Number Publication Date
BE641880A true BE641880A (en) 1964-04-16

Family

ID=27463499

Family Applications (1)

Application Number Title Priority Date Filing Date
BE641880A BE641880A (en) 1962-12-27 1963-12-27

Country Status (5)

Country Link
BE (1) BE641880A (en)
FR (1) FR3150M (en)
GB (1) GB1080599A (en)
LU (1) LU45106A1 (en)
NL (1) NL302572A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107540413A (en) * 2017-09-14 2018-01-05 精晶药业股份有限公司 A kind of method that urea is extracted in the crystalline mother solution from aspartic acid ornithine

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2495608A1 (en) * 1980-12-04 1982-06-11 Morelle Jean NEW ASPARTIC ACID DERIVATIVES AND THEIR USES
DK1824563T3 (en) 2004-11-26 2010-05-31 Ucl Business Plc Compositions comprising ornithine and phenylacetate or phenylbutyrate for the treatment of hepatic encephalopathy
LT3686183T (en) 2009-04-03 2022-11-10 Ocera Therapeutics, Inc. L-ornithine phenyl acetate and methods of making thereof
WO2010144498A2 (en) 2009-06-08 2010-12-16 Ucl Business Plc Treatment of portal hypertension and restoration of liver function using l-ornithine phenylacetate
CN103502203B (en) 2010-10-06 2016-09-07 欧塞拉治疗有限公司 The method preparing L-Orn phenyl acetate salt
AU2015353703B2 (en) 2014-11-24 2021-04-01 Ucl Business Plc Treatment of diseases associated with hepatic stellate cell activation using ammonia-lowering therapies
CA2995823A1 (en) 2015-08-18 2017-02-23 Ocera Therapeutics, Inc. Treatment and prevention of muscle loss using l-ornithine in combination with at least one of phenylacetate and phenylbutyrate
US11066352B2 (en) 2017-05-11 2021-07-20 Ocera Therapeutics, Inc. Processes of making L-ornithine phenylacetate

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107540413A (en) * 2017-09-14 2018-01-05 精晶药业股份有限公司 A kind of method that urea is extracted in the crystalline mother solution from aspartic acid ornithine

Also Published As

Publication number Publication date
LU45106A1 (en) 1964-02-24
FR3150M (en) 1965-02-22
GB1080599A (en) 1967-08-23
NL302572A (en)

Similar Documents

Publication Publication Date Title
BE616548R (en)
BE628342A (en)
BE614566A (en)
BE380301A (en)
BE489310A (en)
BE538252A (en)
BE538831A (en)
BE541929A (en)
BE553896A (en)
BE559145A (en)
BE586180A (en)
BE592434A (en)
BE599783A (en)
BE604335A (en)
BE608197A (en)
BE609543A (en)
BE612190A (en)
BE612311A (en)
BE612464A (en)
BE612847A (en)
BE612926A (en)
BE613108A (en)
BE613190A (en)
BE613298A (en)
BE613319A (en)